EUVIMEDEUVIMED entdecken
Qualitative Studie

A qualitative study exploring the experiences of nurses delivering bacillus Calmette-Guérin therapy

Kristina Førde, Patrick Juliebø-Jones, Herdis Alvsvåg, Birthe Ørskov

British Journal of Nursing · 2025

DOI: 10.12968/bjon.2024.0281 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift British Journal of Nursing, 2025. Verfasst von Kristina Førde und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oncology nurse, Department of Urology, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: BCG Vaccine, Urinary Bladder Neoplasms, Attitude of Health Personnel. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravesical bacillus Calmette-Guérin (BCG) is an effective treatment for preventing recurrence and progression of non-muscle-invasive bladder cancer; however, patients often withdraw early from the treatment. Nurses have an integral role in delivering and overseeing treatment. The aim of this study was to explore nurses’ perspectives on the factors that contribute to patients successfully completing BCG treatment.

Method

Three focus group interviews were conducted with nurses working at different hospitals in Norway. The empirical material was analysed using reflexive thematic analysis.

Findings

The identified themes were ‘relationship and continuity’, ‘knowledge and overview’ and ‘managing side effects’.

Conclusion

The study reveals several areas that nurses experience as contributing to patients completing their BCG treatment. The study also sheds light on how to improve practice through improved nurse training and optimalisation of interdisciplinary collaboration with urologists in order to assess and manage side effects in a more standardised way.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BCG VaccineUrinary Bladder NeoplasmsAttitude of Health PersonnelHumansQualitative ResearchFocus GroupsNorwayFemaleMaleAdult

Stichwörter der Autor:innen

Bacillus Calmette-GuérinFocus group interviewsIntravesical therapyNon-muscle-invasive bladder cancerNurses’ experiencesQualitative study

Substanzen

BCG Vaccine

Autor:innen und Institutionen

  • Oncology nurse, Department of Urology, Haukeland University Hospital, Bergen, Norway.
  • Consultant Urologist, Department of Urology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Professor Emerita, Institute for Nursing, Faculty of Health Sciences, VID Specialised University, Bergen, Norway.
  • Assistant Professor, Institute for Nursing, Faculty of Health Sciences, VID Specialised University, Bergen, Norway.

Zitieren

APA

Førde, K., Juliebø-Jones, P., Alvsvåg, H., & Ørskov, B. (2025). A qualitative study exploring the experiences of nurses delivering bacillus Calmette-Guérin therapy. British Journal of Nursing. https://doi.org/10.12968/bjon.2024.0281

Vancouver

Førde K, Juliebø-Jones P, Alvsvåg H, Ørskov B. A qualitative study exploring the experiences of nurses delivering bacillus Calmette-Guérin therapy. British Journal of Nursing. 2025. doi:10.12968/bjon.2024.0281

BibTeX
@article{Frde2025,
  author = {Førde, Kristina and Juliebø-Jones, Patrick and Alvsvåg, Herdis and Ørskov, Birthe},
  title = {A qualitative study exploring the experiences of nurses delivering bacillus Calmette-Guérin therapy},
  journal = {British Journal of Nursing},
  year = {2025},
  doi = {10.12968/bjon.2024.0281}
}
Kostenlos starten →